H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 94 Citations 40,527 501 World Ranking 140 National Ranking 2
Medicine D-index 96 Citations 43,318 572 World Ranking 4486 National Ranking 86

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Virus

Masashi Mizokami mainly investigates Virology, Genotype, Hepatitis B virus, Virus and Hepatitis C virus. His Virology study frequently links to adjacent areas such as Hepatocellular carcinoma. His research in Genotype intersects with topics in Liver disease and Immunology.

His biological study spans a wide range of topics, including Hepatitis B, Serotype and Distribution. As a member of one scientific family, Masashi Mizokami mostly works in the field of Virus, focusing on Hepatitis and, on occasion, Pathology. His work focuses on many connections between Hepatitis C virus and other disciplines, such as Replicon, that overlap with his field of interest in RNA.

His most cited work include:

  • Production of infectious hepatitis C virus in tissue culture from a cloned viral genome (2514 citations)
  • Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. (1953 citations)
  • Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. (1310 citations)

What are the main themes of his work throughout his whole career to date?

Masashi Mizokami mainly focuses on Virology, Hepatitis B virus, Genotype, Hepatitis C virus and Internal medicine. The study incorporates disciplines such as Hepatocellular carcinoma and Immunology in addition to Virology. His Hepatitis B virus research is multidisciplinary, incorporating elements of Hepatitis B and Antigen.

His Genotype research incorporates elements of Liver disease and Polymerase chain reaction. His work deals with themes such as Interferon, Antibody and Hepatitis, which intersect with Hepatitis C virus. His research in Internal medicine focuses on subjects like Gastroenterology, which are connected to Chronic hepatitis.

He most often published in these fields:

  • Virology (60.57%)
  • Hepatitis B virus (31.79%)
  • Genotype (31.65%)

What were the highlights of his more recent work (between 2015-2021)?

  • Internal medicine (25.24%)
  • Hepatitis B virus (31.79%)
  • Virology (60.57%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Internal medicine, Hepatitis B virus, Virology, Gastroenterology and Genotype. He has included themes like Ribavirin and Hepatitis C virus in his Internal medicine study. Masashi Mizokami combines subjects such as Hepatitis B, Antigen and Hepatitis with his study of Hepatitis B virus.

Within one scientific family, he focuses on topics pertaining to Nucleoside under Virology, and may sometimes address concerns connected to Pharmacology. His Gastroenterology research integrates issues from Inflammation, Urine, Hepatitis C and Incidence. His Genotype research is within the category of Genetics.

Between 2015 and 2021, his most popular works were:

  • NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome (145 citations)
  • Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection. (66 citations)
  • Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. (60 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Virus

His primary areas of study are Internal medicine, Hepatitis B virus, Gastroenterology, Virology and Hepatitis B. His studies in Hepatitis B virus integrate themes in fields like Signal transduction, Signal transducing adaptor protein, Stimulator of interferon genes and Colorectal surgery, Abdominal surgery. A large part of his Virology studies is devoted to Viral replication.

The concepts of his Hepatitis B study are interwoven with issues in Chemokine, Immune system and HBsAg. His Hepatitis C study combines topics from a wide range of disciplines, such as Clinical trial, Kidney disease, Sofosbuvir, Genotype and Ledipasvir. His Cirrhosis study incorporates themes from Liver biopsy, Cohort and Hepatitis C virus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

Takaji Wakita;Thomas Pietschmann;Takanobu Kato;Takanobu Kato;Tomoko Date.
Nature Medicine (2005)

3150 Citations

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.

Yasuhito Tanaka;Nao Nishida;Masaya Sugiyama;Masayuki Kurosaki.
Nature Genetics (2009)

2675 Citations

Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes.

Peter Simmonds;Jens Bukh;Christophe Combet;Gilbert Deléage.
Hepatology (2005)

2017 Citations

A proposed system for the nomenclature of hepatitis C viral genotypes

Peter Simmonds;Alfredo Alberti;Harvey J. Alter;Ferruccio Bonino.
Hepatology (1994)

1287 Citations

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C

J.Y.N Lau;G.L Davis;J Kniffen;K.-P Qian.
The Lancet (1993)

1215 Citations

Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon

Takanobu Kato;Tomoko Date;Michiko Miyamoto;Akihiro Furusaka.
Gastroenterology (2003)

731 Citations

Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.

Anna S. Lok;Fabien Zoulim;Stephen Locarnini;Angeline Bartholomeusz.
Hepatology (2007)

669 Citations

New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a.

O Ohno;M Mizokami;R R Wu;M G Saleh.
Journal of Clinical Microbiology (1997)

633 Citations

Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization

B Robertson;G Myers;C Howard;T Brettin.
Archives of Virology (1998)

585 Citations

A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C

Etsuro Orito;Masashi Mizokami;Hiroshi Sakugawa;Kojiro Michitaka.
Hepatology (2001)

583 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Masashi Mizokami

Takaji Wakita

Takaji Wakita

National Institutes of Health

Publications: 254

Kazuaki Chayama

Kazuaki Chayama

Hiroshima University

Publications: 176

Yasuhito Tanaka

Yasuhito Tanaka

Nagoya University

Publications: 167

Jia-Horng Kao

Jia-Horng Kao

National Taiwan University

Publications: 156

Hiromitsu Kumada

Hiromitsu Kumada

Fukuoka University

Publications: 147

Jens Bukh

Jens Bukh

University of Copenhagen

Publications: 136

Jean-Michel Pawlotsky

Jean-Michel Pawlotsky

Université Paris Cité

Publications: 130

Ralf Bartenschlager

Ralf Bartenschlager

Heidelberg University

Publications: 129

Man-Fung Yuen

Man-Fung Yuen

University of Hong Kong

Publications: 118

Thomas F. Baumert

Thomas F. Baumert

University of Strasbourg

Publications: 116

Fabien Zoulim

Fabien Zoulim

Inserm : Institut national de la santé et de la recherche médicale

Publications: 110

Ching-Lung Lai

Ching-Lung Lai

University of Hong Kong

Publications: 107

Fumitaka Suzuki

Fumitaka Suzuki

National Taiwan University

Publications: 106

Jean Dubuisson

Jean Dubuisson

Institut Pasteur

Publications: 105

Osamu Yokosuka

Osamu Yokosuka

Chiba University

Publications: 104

Ding-Shinn Chen

Ding-Shinn Chen

National Taiwan University

Publications: 104

Something went wrong. Please try again later.